BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1275 related articles for article (PubMed ID: 8786872)

  • 1. Effect of interferon-alpha-2b on the enhancement of tumour uptake of 99Tcm-labelled monoclonal antibodies.
    Li J; Duggaraju R; Maish DR; Thakur ML
    Nucl Med Commun; 1996 Apr; 17(4):346-52. PubMed ID: 8786872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha-2b immunoconjugate for improving immunoscintigraphy and immunotherapy.
    Pallela VR; Rao SP; Thakur ML
    J Nucl Med; 2000 Jun; 41(6):1108-13. PubMed ID: 10855643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved antibody targeting with interferon-alpha-2b conjugate.
    Thakur ML; Li J; Donegan M; Pallela VR; Kolan H; Duggaraju R; Maish D; Srivastava S
    J Immunother; 1997 May; 20(3):194-201. PubMed ID: 9181457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoscintigraphy of human colon cancer xenografts in nude mice using a second-generation TAG-72 monoclonal antibody labelled with 99Tcm.
    Reilly RM; Ng K; Polihronis J; Shpitz B; Ngai WM; Kirsh JC; Gallinger S; Stern H
    Nucl Med Commun; 1994 May; 15(5):379-87. PubMed ID: 8047323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of biological response modifiers in the enhancement of tumor uptake of technetium-99m labeled macromolecules. A preliminary report.
    Thakur ML; DeFulvio J; Tong J; John E; McDevitt MR; Damjanov I
    J Immunol Methods; 1992 Aug; 152(2):209-16. PubMed ID: 1500731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interleukin-2 on the biodistribution of technetium-99m-labelled anti-CEA monoclonal antibody in mice bearing human tumour xenografts.
    Nakamura K; Kubo A
    Eur J Nucl Med; 1994 Sep; 21(9):924-9. PubMed ID: 7995285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement by affinity chromatography on antiidiotypic monoclonal antibodies (MAbs) of immunoreactivity and in vivo targeting of radiolabelled anti-HMW-MAA MAb TP61.5 in nude mice bearing human melanoma lesions.
    Temponi M; Fawwaz RA; Kekish U; Wang TS; Ferrone S
    Int J Cancer; 1991 Oct; 49(4):624-30. PubMed ID: 1917164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.
    Stalteri MA; Mather SJ
    Eur J Nucl Med; 1996 Feb; 23(2):178-87. PubMed ID: 8925853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: improvement of tumour uptake by internalisation.
    Kwa HB; Wesseling J; Verhoeven AH; van Zandwijk N; Hilkens J
    Br J Cancer; 1996 Feb; 73(4):439-46. PubMed ID: 8595157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
    Gridley DS; Slater JM; Stickney DR
    J Biol Response Mod; 1989 Dec; 8(6):593-602. PubMed ID: 2513378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different biodistribution of 99mTc-labelled chimeric mouse-human monoclonal antibody between athymic mice model and human.
    Oriuchi N; Watanabe N; Sugiyama S; Higuchi T; Imai K; Yamanaka H; Hashimoto M; Kanda H; Endo K
    Br J Cancer; 1996 Jun; 73(12):1466-72. PubMed ID: 8664114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha induced changes in CEA expression in patients with CEA-producing tumours.
    Verhaar-Langereis MJ; Bongers V; de Klerk JM; van Dijk A; Blijham GH; Zonnenberg BA
    Eur J Nucl Med; 2000 Feb; 27(2):209-13. PubMed ID: 10755728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmenting of tumor uptake of anti-melanoma antibody MEM136: influence of interferon.
    Li J; Merton DA; Duggaraju R; Thakur ML
    Nucl Med Biol; 1996 Oct; 23(7):873-9. PubMed ID: 8971854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activation.
    Molto L; Alvarez-Mon M; Carballido J; Manzano L; Guillen C; Prieto A; Olivier C; Rodriguez-Zapata M
    Br J Cancer; 1994 Dec; 70(6):1247-51. PubMed ID: 7981084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
    Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
    Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential usefulness of 99mTc-labeled monoclonal antibody A7 for immunoscintigraphy of human pancreatic carcinoma.
    Matsumura H; Otsuji E; Kobayashi S; Okamoto K; Toma A; Yamagishi H
    Anticancer Res; 2001; 21(5):3433-7. PubMed ID: 11848505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with tumor necrosis factor alpha and interferon alpha of a human kidney cancer xenograft in nude mice: evidence for an anticachectic effect of interferon alpha.
    Bassukas ID; Hofmockel G; Maurer-Schultze B
    Anticancer Res; 1994; 14(1A):237-45. PubMed ID: 8166454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.
    Desrues B; Léna H; Brichory F; Ramée MP; Toujas L; Delaval P; Dazord L
    Br J Cancer; 1995 Nov; 72(5):1076-82. PubMed ID: 7577450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta.
    Johns TG; Mackay IR; Callister KA; Hertzog PJ; Devenish RJ; Linnane AW
    J Natl Cancer Inst; 1992 Aug; 84(15):1185-90. PubMed ID: 1378904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiolocalization of pancreatic carcinoma xenografts in nude mice with radiolabeled chimeric Fab fragments of anti-carcinoembryonic antigen monoclonal antibody A10.
    Kamigaki T; Yamamoto M; Ohyanagi H; Saitoh Y
    Pancreas; 1995 Apr; 10(3):258-64. PubMed ID: 7624303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.